Trademark: 97282606
Word

Status
Pending
Status Code
730
Status Date
Thursday, January 18, 2024
Serial Number
97282606
Mark Type
2000
Filing Date
Thursday, February 24, 2022
Published for Opposition
Tuesday, October 3, 2023

Trademark Owner History
SUMITOMO PHARMA CO., LTD. - Owner At Publication
Sumitomo Dainippon Pharma Co., Ltd. - Original Applicant

Classifications
9 Motion detectors; Recorded computer software for use in medical treatment planning, namely, for analyzing medical data to assist in providing clinical interpretations; Recorded computer software for patient care data management and analytics; Recorded computer software for identity verification in the field of medical therapy treatment; Downloadable computer software for simulating disease for the purpose of medical treatment and diagnosis; Downloadable computer software applications for visualization and simulation, in particular for the visualization of the anatomy in three-dimensions, for use in simulation exercises by patients and medical workers; Recorded computer software and application software for mobile devices, smartphones and tablet computers for providing, transmitting, accessing, editing, managing and sharing data and digital content related to wellness and health care; Downloadable computer and cloud computing software for providing, transmitting, accessing, editing, managing and sharing data and digital content related to nursing care and welfare; Downloadable computer game software for simulating disease; Downloadable computer game software for use in simulation exercises by patients and medical workers; Downloadable video game software for managing mental diseases, supporting physical training, mindfulness and daily wellness; Virtual reality headsets
5 Pharmaceutical preparations, namely, anti-inflammatories; Pharmaceutical preparations for the prevention and treatment of disorders and diseases of the central nervous system, peripheral nervous system, cardiovascular system, endocrine system, metabolic system, renal system, gastroenterological system, and ophthalmologic system; Pharmaceutical preparations for the prevention and treatment of hematologic and oncologic disorders and diseases, psychiatric disorders and diseases, allergic disorders and diseases and disorders and diseases of the immune system, connective tissue and joints; Pharmaceutical preparations for the prevention and treatment of cancer; Pharmaceutical preparation for use in chemotherapy; Pharmaceutical preparations for the prevention and treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of disorders and diseases of the respiratory system; Pharmaceutical preparations for the prevention and treatment of disorders and diseases of the urogenital system; Pharmaceutical preparations for the prevention and treatment of disorders and diseases of the dermatologic system; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for hereditary diseases; Pharmaceutical diagnostic preparations for medical purposes; Pharmaceutical diagnostic reagents for medical use; Biologic preparations for medical and therapeutic purposes, namely, vaccines; Biologic preparations for medical and therapeutic purposes, namely, cells for medical or clinical use; Biologic preparations for medical and therapeutic purposes, namely, nucleic acid sequences for medical purposes
1 Chemical additives for use in the manufacture of food, cosmetics and pharmaceuticals; Humectants; Chemical additives for photoresists used in the manufacture of semiconductors
44 Medical screening; Mental health screening services; Providing medical information; Provision of health information; Medical testing for diagnostic or treatment purposes
10 Body rehabilitation apparatus for medical purposes, namely, for treatment of impaired motor function relating to hand paralysis, leg paralysis
42 Providing on-line non-downloadable software for management of data for home health and assisted living care; Providing on-line non-downloadable software for the control of sensors in the field of home health and hospice care; Providing on-line non-downloadable software for use in medical treatment planning, namely, for analyzing medical data to assist in providing clinical interpretations; Providing on-line non-downloadable software for patient care data management and analytics; Providing on-line non-downloadable software for identity verification in the field of medical therapy treatment; Providing on-line non-downloadable software for simulating disease for the purpose of medical treatment and diagnosis; Providing on-line non-downloadable software applications for visualization and simulation, in particular for the visualization of the anatomy in three-dimensions, for use in simulation exercises by patients and medical workers; Providing on-line non-downloadable software for mobile devices, smartphones and tablet computers for providing, transmitting, accessing, editing, managing and sharing data and digital content related to wellness and health care; Providing on-line non-downloadable software and cloud computing software for providing, transmitting, accessing, editing, managing and sharing data and digital content related to nursing care and welfare; Computer software design, computer programming, or maintenance of computer software in the field(s) of medicine, the prevention, treatment and management of illness, health care delivery
The mark consists of four lines crossing to form a diamond-shaped design.

Trademark Events
Jan 20, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 18, 2024
Sou Extension 1 Granted
Jan 18, 2024
Sou Extension 1 Filed
Jan 18, 2024
Sou Teas Extension Received
Nov 28, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 3, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 3, 2023
Published For Opposition
Sep 13, 2023
Notification Of Notice Of Publication E-Mailed
Aug 28, 2023
Approved For Pub - Principal Register
Jul 17, 2023
Notification Of Non-Final Action E-Mailed
Jul 17, 2023
Non-Final Action E-Mailed
Jul 17, 2023
Non-Final Action Written
Jul 11, 2023
Examiner's Amendment Entered
Jul 11, 2023
Notification Of Examiners Amendment E-Mailed
Jul 11, 2023
Examiners Amendment E-Mailed
Jul 11, 2023
Examiners Amendment -Written
Jun 2, 2023
Teas/Email Correspondence Entered
Jun 2, 2023
Correspondence Received In Law Office
Jun 2, 2023
Teas Response To Office Action Received
Mar 10, 2023
Application Extension Granted/Receipt Provided
Mar 10, 2023
Application Extension To Response Period - Received
Dec 13, 2022
Notification Of Non-Final Action E-Mailed
Dec 13, 2022
Non-Final Action E-Mailed
Dec 13, 2022
Non-Final Action Written
Dec 8, 2022
Assigned To Examiner
Sep 28, 2022
Automatic Update Of Assignment Of Ownership
Mar 17, 2022
Preliminary/Voluntary Amendment - Entered
Mar 10, 2022
Assigned To Lie
Mar 10, 2022
Assigned To Lie
Mar 8, 2022
Teas Voluntary Amendment Received
Mar 3, 2022
Notice Of Design Search Code E-Mailed
Mar 2, 2022
New Application Office Supplied Data Entered
Feb 28, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24